HK1250655A1 - Aqueous pharmaceutical formulation of tapentadol for oral administration - Google Patents
Aqueous pharmaceutical formulation of tapentadol for oral administrationInfo
- Publication number
- HK1250655A1 HK1250655A1 HK18110209.6A HK18110209A HK1250655A1 HK 1250655 A1 HK1250655 A1 HK 1250655A1 HK 18110209 A HK18110209 A HK 18110209A HK 1250655 A1 HK1250655 A1 HK 1250655A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tapentadol
- oral administration
- pharmaceutical formulation
- aqueous pharmaceutical
- aqueous
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161449287P | 2011-03-04 | 2011-03-04 | |
EP11003601 | 2011-05-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1250655A1 true HK1250655A1 (en) | 2019-01-11 |
Family
ID=71452834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18110209.6A HK1250655A1 (en) | 2011-03-04 | 2014-06-24 | Aqueous pharmaceutical formulation of tapentadol for oral administration |
Country Status (3)
Country | Link |
---|---|
ES (1) | ES2796370T3 (en) |
HK (1) | HK1250655A1 (en) |
HU (1) | HUE049350T2 (en) |
-
2012
- 2012-03-02 ES ES17189271T patent/ES2796370T3/en active Active
- 2012-03-02 HU HUE17189271A patent/HUE049350T2/en unknown
-
2014
- 2014-06-24 HK HK18110209.6A patent/HK1250655A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2796370T3 (en) | 2020-11-26 |
HUE049350T2 (en) | 2020-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL254854A0 (en) | Aqueous pharmaceutical formulation of tapentadol for oral administration | |
EP2747563A4 (en) | Compositions and methods thereof for oral administration of drugs | |
EP2906202A4 (en) | Oral drug delivery formulations | |
IL228709A0 (en) | Unit dose form for oral administration | |
EP2661273A4 (en) | Pharmaceutical compositions of iron for oral administration | |
HRP20160989T1 (en) | Solution for oral administration | |
HK1199843A1 (en) | Oral spray formulations and methods for administration of sildenafil | |
EP2665471A4 (en) | Controlled release oral pharmaceutical dosage forms comprising mgbg | |
EP2567710A4 (en) | Aqueous pharmaceutical system for the administration of drugs to the nails | |
PL2702060T3 (en) | Acid addition salts of risperidone and pharmaceutical compositions thereof | |
ZA201308905B (en) | Nasal pharmaceutical formulation comprising fluticasone | |
AU2012265231A1 (en) | Nasal pharmaceutical formulation | |
IL227651A0 (en) | Pharmaceutical formulation for topical administration comprising b220 | |
PL2714042T3 (en) | An analgesic pharmaceutical composition for oral administration | |
HK1250655A1 (en) | Aqueous pharmaceutical formulation of tapentadol for oral administration | |
HUP0900482A2 (en) | Pharmaceutical formulation for oral administration |